Doctors who prescribe and patients who use transdermal scopolamine patches should first be warned of the severity and duration of scopolamine withdrawal syndrome, “neither of which are apparent from the current product labeling,” said Rober. E. Feder, with the Catholic Medical Center in Manchester, New Hampshire, in a March/April 1999 Letter to the Editor for the medical journal Clinical Neuropharmacology. Transdermal scopolamine patches are used to treat motion sickness. Feder explains that the product had been withdrawn for several years by the manufacturer before being reintroduced. Feder wrote the letter to bring to light the existence and severity of a ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.